dc.contributor.author | Okulu, Emel | |
dc.contributor.author | Hirfanoğlu, İbrahim Murat | |
dc.contributor.author | Satar, Mehmet | |
dc.contributor.author | Erdeve, Ömer | |
dc.contributor.author | Koç, Esin | |
dc.contributor.author | Özlü, Ferda | |
dc.contributor.author | Gökçe, Mahmut | |
dc.contributor.author | Armangil, Didem | |
dc.contributor.author | Sündüs Uygun, Saime | |
dc.date.accessioned | 2023-12-26T07:00:46Z | |
dc.date.available | 2023-12-26T07:00:46Z | |
dc.date.issued | 2023 | en_US |
dc.identifier.citation | Okulu, E., Hirfanoğlu, İ. M., Satar, M., Erdeve, Ö., Koç, E., Özlü, F. ... Sündüs Uygun, S. (2023). An observational, multicenter, registry-based cohort study of Turkish Neonatal Society in neonates with Hypoxic ischemic encephalopathy. PloS One, 18(12), e0295759-e0295759. https://dx.doi.org/10.1371/journal.pone.0295759 | en_US |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://dx.doi.org/10.1371/journal.pone.0295759 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/12071 | |
dc.description.abstract | BACKGROUND: Hypoxic ischemic encephalopathy (HIE) is a significant cause of mortality and short- and long-term morbidities. Therapeutic hypothermia (TH) has been shown to be the standard care for HIE of infants ≥36 weeks gestational age (GA), as it has been demonstrated to reduce the rates of mortality, and adverse neurodevelopmental outcomes. This study aims to determine the incidence of HIE in our country, to assess the TH management in infants with HIE, and present short-term outcomes of these infants. METHODS: The Turkish Hypoxic Ischemic Encephalopathy Online Registry database was established for this multicenter, prospective, observational, nationally-based cohort study to evaluate the data of infants born at ≥34 weeks GA who displayed evidence of neonatal encephalopathy (NE) between March, 2020 and April 2022. RESULTS: The incidence of HIE among infants born at ≥36 weeks GA (n = 965) was 2.13 per 1000 live births (517:242440), and accounting for 1.55% (965:62062) of all neonatal intensive care unit admissions. The rates of mild, moderate and severe HİE were 25.5% (n = 246), 58.9% (n = 568), and 15.6% (n = 151), respectively. Infants with severe HIE had higher rates of abnormal magnetic resonance imaging (MRI) findings, and mortality (p<0.001). No significant difference in mortality and abnormal MRI results was found according to the time of TH initiation ([removed]6 h) (p>0.05). TH was administered to 85 (34.5%) infants with mild HIE, and of those born of 34-35 weeks of GA, 67.4% (n = 31) received TH. A total of 58 (6%) deaths were reported with a higher mortality rate in infants born at 34-35 weeks of GA (OR 3.941, 95% Cl 1.446-10.7422, p = 0.007). CONCLUSION: The incidence of HIE remained similar over time with a reduction in mortality rate. The timing of TH initiation, whether [removed] | en_US |
dc.language.iso | eng | en_US |
dc.publisher | San Francisco, CA | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Turkish Neonatal Society | en_US |
dc.subject | Registry-Based Cohort Study | en_US |
dc.subject | Hypoxic Ischemic Encephalopathy | en_US |
dc.title | An observational, multicenter, registry-based cohort study of Turkish Neonatal Society in neonates with Hypoxic ischemic encephalopathy | en_US |
dc.type | article | en_US |
dc.relation.ispartof | PloS One | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı | en_US |
dc.authorid | 0000-0003-1735-4318 | en_US |
dc.identifier.volume | 18 | en_US |
dc.identifier.issue | 12 | en_US |
dc.identifier.startpage | e0295759 | en_US |
dc.identifier.endpage | e0295759 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.1371/journal.pone.0295759 | en_US |
dc.institutionauthor | Taştekin, Ayhan | |
dc.identifier.wosquality | Q2 | en_US |
dc.identifier.wos | 001158744900075 | en_US |
dc.identifier.scopus | 2-s2.0-85179770987 | en_US |
dc.identifier.pmid | 38096201 | en_US |
dc.identifier.scopusquality | Q1 | en_US |